openPR Logo
Press release

Gouty Arthritis Market Outlook Report 2024 | Size, Trends, Analysis, Insights, Overview By 2033

Gouty Arthritis Market Outlook

Gouty Arthritis Market Outlook

"The Business Research Company recently released a comprehensive report on the Global Gouty Arthritis Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp

According to The Business Research Company's, The gouty arthritis market size has grown strongly in recent years. It will grow from $3.21 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to the high prevalence of chronic diseases, increased alcohol intake, an increase in the elderly population, growing acceptance of enhanced regeneration therapies, and rising healthcare expenditure.

The gouty arthritis market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to improvements in healthcare infrastructure, increased obesity, an increased incidence of gout, and increasing awareness among people. Major trends in the forecast period include growing demand for effective treatment options, regenerative therapies, technological advancements, product launches, and regulatory approvals.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Market Drivers and Trends:

The increasing prevalence of obesity is expected to propel the growth of the gouty arthritis market going forward. Obesity is a medical disorder characterized by the buildup of extra body fat to the point where it threatens an individual's health and is frequently measured using the body mass index (BMI). The rate of obesity is rising due to increased consumption of high-calorie, processed foods and sedentary lifestyles. Obesity contributes to gouty arthritis by increasing the production of uric acid and reducing the body's ability to excrete it, leading to the accumulation of uric acid crystals in the joints. Additionally, excess body weight places more stress on joints, exacerbating the inflammation and pain associated with gout. For instance, in March 2022, according to the World Health Organization, a Switzerland-based specialized United Nations agency responsible for worldwide public health, around 1 billion individuals, comprising 650 million adults, 340 million teenagers, and 39 million children, were classified as obese, with this figure continuing to rise. Furthermore, the projections indicate that by 2025, approximately 167 million adults and children will suffer health consequences due to excess weight. Therefore, the increasing prevalence of obesity is driving the growth of the gouty arthritis market.

Major companies operating in the gouty arthritis market are increasing their efforts to develop novel products, such as cortrophin gel, to provide more effective and targeted therapies for managing the condition. Cortrophin gel, also known as repository corticotropin injection, is a purified form of the adrenocorticotropic hormone (ACTH). It is used to treat various inflammatory and autoimmune conditions, including gouty arthritis. For instance, in October 2023, ANI Pharmaceuticals, a US-based pharmaceutical company, received approval from the Food and Drug Administration for a new 1-mL vial size of Purified Cortrophin Gel. This product is intended for the adjunctive treatment of certain patients experiencing acute gouty arthritis flares. Cortrophin Gel is currently the only FDA-approved adrenocorticotropic hormone (ACTH) therapy indicated for treating appropriate patients with acute gouty arthritis flares.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.

Gouty Arthritis Market 2024 Key Insights:

• The gouty arthritis market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%.
• The Impact Of Obesity On The Gouty Arthritis Market
• Innovative Options In Gouty Arthritis Treatment
• North America was the largest region in the gouty arthritis market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=16070&type=smp

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gouty Arthritis Market Outlook Report 2024 | Size, Trends, Analysis, Insights, Overview By 2033 here

News-ID: 3707812 • Views:

More Releases from The Business research company

Key Trends Reshaping the Nucleic Acid Extraction Instruments And Reagents Market: Innovation In Nucleic Acid Extraction With LGC Biosearch Technologies Launches Rapid Sbeadex Lightning Method Industry Transformation
Key Trends Reshaping the Nucleic Acid Extraction Instruments And Reagents Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Nucleic Acid Extraction Instruments And Reagents Market Size Growth Forecast: What to Expect by 2025? The market for nucleic acid extraction instruments and reagents has experienced a robust growth in the recent past. The market value is projected to rise from $4.56 billion in 2024 to $4.97 billion in
Mobile ECG Devices Market Set To Soar Due To Escalating Incidence Of Heart-Related Conditions: Transformative Forces Shaping the Mobile ECG Devices Market Landscape in 2025
Mobile ECG Devices Market Set To Soar Due To Escalating Incidence Of Heart-Relat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Mobile ECG Devices Industry Market Size Be by 2025? In the past few years, the market size for mobile ECG devices has seen significant expansion. The growth rate is expected to rise from $115.35 billion in 2024 to $121.39 billion in 2025, indicating a compound annual
Steady Expansion Forecast for Liver Cancer Diagnostics Market, Projected to Reach $13.71 Billion by 2029
Steady Expansion Forecast for Liver Cancer Diagnostics Market, Projected to Reac …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Liver Cancer Diagnostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for liver cancer diagnostics has seen significant expansion in the past few years. The market, which was valued at $9.69 billion in 2024, is expected to rise to $10.32 billion in
Emerging Laser Atherectomy Devices Market Trends: Product Innovations In The Laser Atherectomy Devices Market Shaping the Future of the Industry
Emerging Laser Atherectomy Devices Market Trends: Product Innovations In The Las …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Laser Atherectomy Devices Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been significant growth in the market size for laser atherectomy devices. The market is projected to expand from $1.22 billion in 2024 to $1.3 billion in 2025, reflecting a compound annual growth

All 5 Releases


More Releases for Gouty

Gouty Arthritis (Gout) Market 2025-2034 Business Outlook, Critical Insight and G …
Introduction Gout is a chronic, inflammatory form of arthritis caused by the accumulation of uric acid crystals in the joints, leading to episodes of severe pain, swelling, and stiffness. It primarily affects the feet, ankles, and knees, but can also impact other joints if left untreated. Historically known as the "disease of kings" due to its association with dietary excess, gout today is increasingly recognized as a major public health issue
Growth Rate Of Gouty Arthritis (Gout) Market from 2018 to 2027
The Gouty Arthritis (Gout) Market report offers a deep analysis of the Gouty Arthritis (Gout) trade. It demonstrates a quick outline of trade knowledge and key Information like Key Manufacturers , Types, Application, Table Of Content, etc of the market. The report highlights Top Venders from the worldwide and Gouty Arthritis (Gout) Market along with their worth of the Industry to see their progress. The worldwide Gouty Arthritis (Gout) analysis
Gouty Arthritis Market Opportunity Analysis, 2018-2026
Gouty arthritis is characterized by intense joint pain due to deposition of uric acid crystals. Symptoms of gouty arthritis include redness and swelling of joints and intense pain. The condition can be treated with the help of medication. Uric acid is deposited either due to its excess intake or body’s inability to process it leading to inflammation of joint sites such as ankles and toes or wrist. Untreated gouty arthritis
Gouty Arthritis Market - Strategic Assessment and Forecast Till 2024
Affecting approximately 1 in 40 adults, Gouty arthritis is characterized by severe swelling and attacks of pain, tenderness, redness, warmth and swelling in the joints that result from abnormal metabolism of uric acid in the tissues and blood. Usually, the joint at the base of the big toe gets affected due to redness, stiffness, swelling and burning pain. High blood pressure, high cholesterol, diabetes and heart disease may increase of
Global Outlook for Gouty Arthritis Market By Key Trends and Analysis 2024
Affecting approximately 1 in 40 adults, Gouty arthritis is characterized by severe swelling and attacks of pain, tenderness, redness, warmth and swelling in the joints that result from abnormal metabolism of uric acid in the tissues and blood. Usually, the joint at the base of the big toe gets affected due to redness, stiffness, swelling and burning pain. High blood pressure, high cholesterol, diabetes and heart disease may increase of
Gouty Arthritis Market: Value chain and stakeholder analysis 2016 - 2024
Affecting approximately 1 in 40 adults, Gouty arthritis is characterized by severe swelling and attacks of pain, tenderness, redness, warmth and swelling in the joints that result from abnormal metabolism of uric acid in the tissues and blood. Usually, the joint at the base of the big toe gets affected due to redness, stiffness, swelling and burning pain. High blood pressure, high cholesterol, diabetes and heart disease may increase of